Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Chen

Showing results (191-200 of 311) with videos related to

Pageof 32
Sort By:
Bioresearch Open Access|June 30, 2016
Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone FormationJustine Tanjaya, Yulong Zhang, Soonchul Lee, et al.
BMC Women'S Health|April 18, 2025
Barriers and facilitators to accessing post sexual-based violence health services among young women attending higher education institutions in NigeriaAjoke Esther Ogedegbe, Zhong Eric Chen, Oluwafemi Adeagbo, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2012
A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancerDaniel J Renouf, Stephen Welch, Malcolm J Moore, et al.
ACS Pharmacology & Translational Science|September 14, 2023
First Potent Macrocyclic A<sub>3</sub> Adenosine Receptor Agonists Reveal G-Protein and β-Arrestin2 Signaling PreferencesDilip K Tosh, Courtney L Fisher, Veronica Salmaso, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 2, 2017
Phase II open label pilot trial of aprepitant and palonosetron for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic FOLFOX chemotherapy for the treatment of colorectal cancerJoseph S Bubalo, Jon D Herrington, Marc Takemoto, et al.
The American Journal of Pathology|March 18, 2017
Neural EGFL-Like 1 Is a Downstream Regulator of Runt-Related Transcription Factor 2 in Chondrogenic Differentiation and MaturationChenshuang Li, Jie Jiang, Zhong Zheng, et al.
Biomaterials|April 28, 2015
Pharmacokinetics and osteogenic potential of PEGylated NELL-1 in vivo after systemic administrationJin Hee Kwak, Yulong Zhang, Juyoung Park, et al.
Journal of Molecular Biology|February 7, 2026
ABSEIL: A Polypeptide Helicity and Ensemble Prediction ToolHannah Hortman, Ruiling A Zhang, Roy G Hughes, et al.
Diabetes Technology & Therapeutics|March 23, 2017
Quantification of Basal Insulin Peglispro and Human Insulin in Adipose Tissue Interstitial Fluid by Open-Flow MicroperfusionKatrin Tiffner, Beate Boulgaropoulos, Christian Höfferer, et al.
Plastic and Reconstructive Surgery|February 16, 2017
Combining Smoothened Agonist and NEL-Like Protein-1 Enhances Bone HealingSoonchul Lee, Chenchao Wang, Hsin Chuan Pan, et al.
Pageof 32

Showing results (191-200 of 311) with videos related to

Sort By:
Pageof 32
Bioresearch Open Access|June 30, 2016
Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone FormationJustine Tanjaya, Yulong Zhang, Soonchul Lee, et al.
BMC Women'S Health|April 18, 2025
Barriers and facilitators to accessing post sexual-based violence health services among young women attending higher education institutions in NigeriaAjoke Esther Ogedegbe, Zhong Eric Chen, Oluwafemi Adeagbo, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2012
A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancerDaniel J Renouf, Stephen Welch, Malcolm J Moore, et al.
ACS Pharmacology & Translational Science|September 14, 2023
First Potent Macrocyclic A<sub>3</sub> Adenosine Receptor Agonists Reveal G-Protein and β-Arrestin2 Signaling PreferencesDilip K Tosh, Courtney L Fisher, Veronica Salmaso, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 2, 2017
Phase II open label pilot trial of aprepitant and palonosetron for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic FOLFOX chemotherapy for the treatment of colorectal cancerJoseph S Bubalo, Jon D Herrington, Marc Takemoto, et al.
The American Journal of Pathology|March 18, 2017
Neural EGFL-Like 1 Is a Downstream Regulator of Runt-Related Transcription Factor 2 in Chondrogenic Differentiation and MaturationChenshuang Li, Jie Jiang, Zhong Zheng, et al.
Biomaterials|April 28, 2015
Pharmacokinetics and osteogenic potential of PEGylated NELL-1 in vivo after systemic administrationJin Hee Kwak, Yulong Zhang, Juyoung Park, et al.
Journal of Molecular Biology|February 7, 2026
ABSEIL: A Polypeptide Helicity and Ensemble Prediction ToolHannah Hortman, Ruiling A Zhang, Roy G Hughes, et al.
Diabetes Technology & Therapeutics|March 23, 2017
Quantification of Basal Insulin Peglispro and Human Insulin in Adipose Tissue Interstitial Fluid by Open-Flow MicroperfusionKatrin Tiffner, Beate Boulgaropoulos, Christian Höfferer, et al.
Plastic and Reconstructive Surgery|February 16, 2017
Combining Smoothened Agonist and NEL-Like Protein-1 Enhances Bone HealingSoonchul Lee, Chenchao Wang, Hsin Chuan Pan, et al.
Pageof 32